| Autor: |
Ngay Lukusa I; Metabiota Inc., Kinshasa, Democratic Republic of the Congo., Takuo JM; Metabiota Cameroon Ltd., Yaoundé, Centre Region, Cameroon., Lumbu Banza C; Metabiota Inc., Kinshasa, Democratic Republic of the Congo.; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo., Le Doux Diffo J; Metabiota Cameroon Ltd., Yaoundé, Centre Region, Cameroon., Mbala Kingebeni P; Metabiota Inc., Kinshasa, Democratic Republic of the Congo.; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo., Ntumvi NF; Metabiota Cameroon Ltd., Yaoundé, Centre Region, Cameroon., Atibu Losoma J; Metabiota Inc., Kinshasa, Democratic Republic of the Congo., Tamoufe U; Metabiota Cameroon Ltd., Yaoundé, Centre Region, Cameroon., Gillis A; Metabiota Inc., San Francisco, California, USA.; Development Alternatives, Inc., Washington, DC, USA., LeBreton M; Mosaic, Yaoundé, Centre Region, Cameroon., Ayukekbong J; Metabiota Inc., Nanaimo, British Columbia, Canada.; Southbridge Care, Cambridge, Ontario, Canada., Joly DO; Metabiota Inc., Nanaimo, British Columbia, Canada.; Nyati Health Consulting, Nanaimo, British Columbia, Canada., Schneider BS; Metabiota Inc., San Francisco, California, USA.; Etiologic, Oakland, California, USA.; Pinpoint Science, San Francisco, California, USA., Monagin C; Metabiota Inc., San Francisco, California, USA.; One Health Institute, School of Veterinary Medicine, University of California, Davis, Davis, California, USA., Makuwa M; Metabiota Inc., Kinshasa, Democratic Republic of the Congo.; Labyrinth Global Health, St. Petersburg, Florida, USA., Wolfe ND; Metabiota Inc., San Francisco, California, USA., Rubin EM; Metabiota Inc., San Francisco, California, USA., Muyembe-Tamfum JJ; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo., Lange CE; Metabiota Inc., Nanaimo, British Columbia, Canada.; Labyrinth Global Health, St. Petersburg, Florida, USA. |
